Pedia Reference compendium

Card Set Information

Author:
NinaTolentino
ID:
302998
Filename:
Pedia Reference compendium
Updated:
2015-05-20 00:18:57
Tags:
Flixotide
Folders:
flixotide MDI
Description:
Flixotide indications
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user NinaTolentino on FreezingBlue Flashcards. What would you like to do?


  1. What are the consideration for step up from  step 3 to step 4?
    Asthma diagnosis, and not well - controlled on low dose ICS
  2. What is the preferred controller choice for step 4?
    Continue controller and refer for specialist assessment
  3. True or False
    FP has a marked anti inflammatory effects in the lungs
    True
  4. What are the 2 formats of Flixotide?
    • A. MDI
    • B. Nebules
  5. What are MDI Strengths?
    • A. 125mcg/120 actuation
    • B. 125mcg/60 actuation
    • C. 50 mcg / 120 actuations
  6. What are MDI Indications?
    • For 1 year old and More
    • any child who requires preventive asthma medication, including patients not controlled on currently availableprophprophylactic medication
  7. What is MDI onset of therapeutic Effect?
    • A. Some benefits may be apparent as soon as 24 hours from patients who have not previously received inhaled steroids
    • B. The onset of therapeutic Effect is 4-7 days
  8. What is MDI dosage and Administration for children aged 1 years Old?
    • 50 mcg 2 puffs BID
    • administered via a pediatric space device with a face mask such as babyhaler
  9. What is MDI dosage and Administration for children aged years of age and Over?
  10. 50 -200 mcg BID
    • Mild asthma 100-250 mcg BID
    • Moderate asthma 250-500 mcg BID
    • Severe asthma 50 - 1000 mcg BID
  11. True or False
    Flixotide should be taken regularly even when patients are asymptomatic
    TRUE
  12. True or False
    Flixotide is for inhalation by oral inhalation only
    TRUE
  13. True or False
    It is intended that each prescribed dose is given by a minimum of two inhalations.
    True
  14. True or False
    Inhaled Flixotide is of benefit to younger children in the control of frequent and persistent asthma symptoms
    True
  15. True or False
    clinical trials in 1-4 years old children have shown that the optimal control of Asthma symptoms is achieved with 100 mcg BID  daily, administered via a pediatric spacer device with a face mask such as babyhaler
    True
  16. Flixotide nebules 250 mcg/ml contain how many FP?
    250mcg/ml (plastic ampoules) contain 2 mg of FP as a 2 ml buffered isotonic saline suspension
  17. What is the indication of Flixotide Nebules Indication?
    • For 4 year old and More
    • * treatment of acute exacerbation of Asthma; subsequent maintenance dosing may be more conveniently accomplished using a pressurized MDI  or powder formulation
  18. What is Flixotide Nebules dosage and Administration for children aged 4 years of age and Over?
    1000 mcg BID ( 4 NEBULES)
  19. True or False
    Increasing use of SABA to control asthma symptoms indicates deterioration of Asthma Control
    True
  20. True or False
    sudden and progressive deterioration in asthma control is potentially life threatening and consideration should be given to increasing corticosteroids dosage
    True
  21. True or false
    systemic effects may occur it any inhaled corticosteroid, particularly at high doses prescribed for long periods; these effects are much less likely to occur than with oral corticosteroid.
    True
  22. What are the possible systemic effects of Flixotide?
    • Cushing syndrome
    • Cushingoid features
    • adrenal suppression
    • growth retardation in children and adolescent
    • decrease in bone mineral density
    • cataract and glaucoma
  23. True or False
    It is important that the dose of ICS is titrated to the lowest dose at which effective control system is maintained
    True
  24. True or False
    It is recommended that the height of the children receiving prolonged treatment with ICS is regularly monitored
    True
  25. True or False
    patients transferring from oral steroid to inhaled FP therapy should b treated with special care and adrenocotical function regularly monitored
    True
  26. True or False
    Following introduction of inhaled FP ( Flixotide), withdrawal from systemic therapy should be gradual and patients encouraged to carry a steroid warning card indicating the possible need for additional therapy in times of stress
    True
  27. True or False
    the possibility of impaired adrenal response should always be considered in emergency situations including surgery
    and also elective situations likely to produce stress, especially in patients taking high doses from extended duration of time.
    True
  28. True or False
    Replacement of systemic steroid treatment with inhaled therapy may unmask allergies such as allergic rhinitis or eczema previously controlled by the system drug
    True
  29. True or False
    Treatment with FP should not be stopped abruptly
    True
  30. True or False
    Thee have been very rare reports of increases in blood glucose levels and this should be considered when prescribing to patients with history of DM
    True
  31. True or False
    as with all ICS, special care is necessary in patients with active or quiescent PTB
    True
  32. True or False
    There have been reports of clinically significant drug interactions in patients receiving FP and ritonavir.  Therefore should be avoided
    True
  33. True or False
    As with other inhalation therapy, paradoxical Bronchospasm may occur with an immediate increase in wheezing after dosing. This should be treated immediately with fast acting Bronchodilator.  FP inhaler should be discontinued immediately
    True
  34. True or False
    FP is unlikely to produce an effect on ability to drive and use machine
    True

What would you like to do?

Home > Flashcards > Print Preview